Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -278,666 | -173,983 | -152,631 | -135,840 | -130,466 |
| Depreciation Amortization | -7,456 | -12,293 | -8,571 | 2,369 | 4,949 |
| Accounts receivable | -6,744 | -2,060 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,499 | -1,627 | -924 | N/A | N/A |
| Other Working Capital | 184,441 | 286,173 | 7,819 | -2,982 | -3,224 |
| Other Operating Activity | 39,868 | 38,107 | 29,483 | 26,391 | 24,190 |
| Operating Cash Flow | $-64,058 | $134,317 | $-124,824 | $-110,062 | $-104,551 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,460 | -101,118 | 15,725 | 33,253 | -125,688 |
| PPE Investments | -6,638 | -472 | -168 | -626 | -1,147 |
| Investing Cash Flow | $-13,098 | $-101,590 | $15,557 | $32,627 | $-126,835 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -7,250 |
| Common Stock Issued | 1,793 | 154,417 | 94,783 | 29,140 | 4,426 |
| Other Financing Activity | 0 | 0 | 0 | -575 | -611 |
| Financing Cash Flow | $1,793 | $154,417 | $94,783 | $38,565 | $-3,435 |
| Beginning Cash Position | 224,462 | 37,318 | 51,802 | 90,672 | 325,493 |
| End Cash Position | 149,099 | 224,462 | 37,318 | 51,802 | 90,672 |
| Net Cash Flow | $-75,363 | $187,144 | $-14,484 | $-38,870 | $-234,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,058 | 134,317 | -124,824 | -110,062 | -104,551 |
| Capital Expenditure | -6,638 | -472 | -168 | -626 | -1,147 |
| Free Cash Flow | -70,696 | 133,845 | -124,992 | -110,688 | -105,698 |